Macquarie Group LTD Standard Biotools Inc. Transaction History

Macquarie Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$1.87 - $2.78 $36,666 - $54,510	19,608 New	19,608 $53,000
Q2 2022 Aug 15, 2022	SELL	$1.6 - $3.99 $17,859 - $44,536	-11,162 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$5.5 - $7.41 $50,759 - $68,386	9,229 Added 477.44%	11,162 $74,000
Q1 2021 May 14, 2021	BUY	$3.94 - $7.09 $7,616 - $13,704	1,933 New	1,933 $9,000

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $131M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.